Latest Innovation News

Collins Foods unveiled ambitious growth plans at its 2025 Investor Day, spotlighting rapid expansion in Germany and operational enhancements in Australia and Europe. The company reaffirmed its FY26 profit growth targets, underpinned by digital innovation and brand modernization.

Genetic Signatures Ltd reports a robust start to FY2026 with a 20% quarterly sales increase, driven by new US contracts and strong growth in EMEA and Australia. The company also bolsters its leadership with a new CTO appointment.

HUB24 has reported a record $5.2 billion in net inflows for Q1 FY26, boosting its Funds Under Administration to $146.5 billion and securing the top spot for adviser satisfaction in Australia.

Sky Metals reports significant drilling successes and metallurgical advances at its Tallebung and Doradilla tin projects, supported by a $6.1 million capital raise to accelerate development.

Peppermint Innovation is repositioning as a digital wallet operator targeting the vast Philippine cooperative sector, aiming to scale rapidly and generate predictable revenue from one million active users.

Krakatoa Resources is advancing its Zopkhito Antimony-Gold Project in Georgia with innovative drone LiDAR surveys and dual diamond drilling, moving closer to a maiden JORC resource amid rising demand for critical minerals.

Latitude 66 has inked a binding deal with Iondrive to test innovative Deep Eutectic Solvent technology on cobalt concentrates from its Finnish KSB Project, aiming to boost cost-efficiency and sustainability in critical minerals refining.

Yari Minerals has begun a targeted drilling campaign at its Rolleston South Coal Project to confirm semi-soft metallurgical coal and upgrade its resource classification, setting the stage for a 2026 scoping study.

Advanced Braking Technology Ltd has kicked off FY26 with a 21% rise in product sales revenue and a 66% jump in net profit before tax, underpinned by expanding international demand and progress in autonomous braking systems.

Prominence Energy has extended its agreement to acquire the Gawler Hydrogen Project, allowing more time to secure final regulatory approvals and advance exploration in South Australia.

Actinogen Medical has received approval for an additional $1.87 million research and development tax rebate, bringing its total FY25 rebate to $7.36 million. This funding underpins ongoing clinical trials of its Alzheimer’s and depression therapy candidate, Xanamem.

Audio Pixels Holdings has extended the maturity of $12.3 million in convertible notes to January 2027 and capitalised $4.05 million in accrued interest, enhancing its financial flexibility.